Synthesis and Biological Evaluation of 2-Hydroxy-3-[(2-aryloxyethyl)amino]propyl 4-[(Alkoxycarbonyl)amino]benzoates
Table 1
Structure of the target compounds 19a–23d and comparison of calculated lipophilicities (log ) with determined log values; calculated values of solubility (log ), molar volume (MV [cm3]), surface tension (ST [dyne/cm]), and determined p values, and in vitro antimycobacterial activity (MIC [mol/L]) of compounds compared to ciprofloxacin (CPX), isoniazid (INH), pyrazinamide (PZA), and rifampicin (RIF) standards.
Compound
R1
R2
Log
Log
Log
p
MVa [cm3]
STa [dyne/cm]
MIC [mol/L]
MAP
MI
19a
CH3
2-OCH3
0.3870
2.52
−3.07
8.82
331.92
50.65
275
550
19b
C2H5
2-OCH3
0.3976
2.71
−3.39
8.90
348.43
49.73
128
533
19c
C3H7
2-OCH3
0.4089
3.15
−3.70
8.67
364.93
48.91
64
259
19d
C4H9
2-OCH3
0.4228
3.44
−4.00
8.73
381.44
48.16
62
201
20a
CH3
4-OCH3
0.3881
2.95
−3.12
8.25
331.92
50.65
550
550
20b
C2H5
4-OCH3
0.3999
3.40
−3.44
8.23
348.43
49.73
533
533
20c
C3H7
4-OCH3
0.4108
3.70
−3.75
7.99
364.93
48.91
259
259
20d
C4H9
4-OCH3
0.4241
4.09
−4.05
8.18
381.44
48.16
62
121
21a
CH3
2,6-OCH3
0.3865
2.33
−3.03
9.14
355.92
49.10
516
516
21b
C2H5
2,6-OCH3
0.3956
2.54
−3.34
8.88
372.43
48.32
501
501
21c
C3H7
2,6-OCH3
0.4052
2.84
−3.65
8.90
388.94
47.62
117
487
21d
C4H9
2,6-OCH3
0.4177
3.13
−3.94
8.58
405.44
46.99
59
114
22a
CH3
2-F
0.3904
3.00
−3.51
7.98
316.28
51.45
564
564
22b
C2H5
2-F
0.4011
3.13
−3.84
7.99
341.42
50.42
547
547
22c
C3H7
2-F
0.4206
3.54
−4.15
7.97
348.54
49.51
265
265
22d
C4H9
2-F
0.4341
3.88
−4.46
7.96
364.66
48.69
124
124
23a
CH3
4-F
0.3915
2.63
−3.52
8.04
316.28
51.45
564
564
23b
C2H5
4-F
0.4032
3.21
−3.82
8.09
341.42
50.42
547
547
23c
C3H7
4-F
0.4228
3.66
−4.11
8.16
348.54
49.51
66
265
23d
C4H9
4-F
0.4365
4.16
−4.39
8.08
364.66
48.69
64
258
CPX
—
—
—
—
—
—
—
—
181
181
INH
—
—
—
—
—
—
—
—
>1823
>729
PZA
—
—
—
—
—
—
—
—
>2031
>812
RIF
—
—
—
—
—
—
—
—
>109
—
Calculated for the uncharged molecule; MAP: Mycobacterium avium subsp. paratuberculosis CIT03; MI: Mycobacterium intracellulare.